Correction to: Drug repurposing using computational methods to identify therapeutic options for COVID-19.

IF 1.8 Q4 ENDOCRINOLOGY & METABOLISM

Journal of Diabetes and Metabolic Disorders Pub Date : 2023-07-10 eCollection Date: 2023-12-01 DOI:10.1007/s40200-023-01248-8

Soodeh Mahdian, Azadeh Ebrahim-Habibi, Mahboobeh Zarrabi

引用次数: 0

Abstract

[This corrects the article DOI: 10.1007/s40200-020-00546-9.].

查看原文本刊更多论文

更正:使用计算方法确定COVID-19治疗方案的药物再利用。

[这更正了文章DOI: 10.1007/s40200-020-00546-9]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Diabetes and Metabolic Disorders Medicine-Internal Medicine

CiteScore

4.80

自引率

3.60%

发文量

210

期刊介绍： Journal of Diabetes & Metabolic Disorders is a peer reviewed journal which publishes original clinical and translational articles and reviews in the field of endocrinology and provides a forum of debate of the highest quality on these issues. Topics of interest include, but are not limited to, diabetes, lipid disorders, metabolic disorders, osteoporosis, interdisciplinary practices in endocrinology, cardiovascular and metabolic risk, aging research, obesity, traditional medicine, pychosomatic research, behavioral medicine, ethics and evidence-based practices.As of Jan 2018 the journal is published by Springer as a hybrid journal with no article processing charges. All articles published before 2018 are available free of charge on springerlink.Unofficial 2017 2-year Impact Factor: 1.816.